Sensitization of Ovarian Carcinoma Cells to BCL-xL-Targeting Strategies Through Indirect Modulation of McL-1 Activity by MR22388, a Molecule of the Tripentone Family

Journal of Ovarian Research - United Kingdom
doi 10.1186/1757-2215-6-38
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Inhibition of McL-1 Expression by Citrate Enhances the Effect of BCL-xL Inhibitors on Human Ovarian Carcinoma Cells

Journal of Ovarian Research
GynecologyOncologyObstetrics
2013English

Inhibition of Store-Operated Channels by Carboxyamidotriazole Sensitizes Ovarian Carcinoma Cells to Anti-BclxL Strategies Through McL-1 Down-Regulation

Oncotarget
Oncology
2018English

Modulation of Cell Death by BCL-xL Through Caspase Interaction

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1998English

McL-1 and BCL-xL Sequestration of Bak Confers Differential Resistance to BH3-only Proteins

Cell Death and Differentiation
Cell BiologyMolecular Biology
2018English

McL-1 Is an Important Determinant of the Apoptotic Response to the BH3-mimetic Molecule HA14-1 in Cisplatin-Resistant Ovarian Carcinoma Cells

Molecular Cancer Therapeutics
Cancer ResearchOncology
2009English

McL-1, BCL-XL and MITF Are Diversely Employed in Adaptive Response of Melanoma Cells to Changes in Microenvironment

PLoS ONE
Multidisciplinary
2015English

Expression Profile of BCL-2, BCL-XL, and McL-1 Predicts Pharmacological Response to the BCL-2 Selective Antagonist Venetoclax in Multiple Myeloma Models

Molecular Cancer Therapeutics
Cancer ResearchOncology
2016English

McL-1: A Gateway to TRAIL Sensitization

Cancer Research
Cancer ResearchOncology
2008English

Design, Synthesis and Evaluation of Marinopyrrole Derivatives as Selective Inhibitors of McL-1 Binding to Pro-Apoptotic Bim and Dual McL-1/BCL-xL Inhibitors

European Journal of Medicinal Chemistry
MedicineOrganic ChemistryDrug DiscoveryPharmacology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy